All News

Liraglutide is the first glucagon-like peptide-1 to have a generic equivalent for both type 2 diabetes and obesity indications.

The approved vaccines include Novavax’s Nuvaxovid and Moderna’s Spikevax and mNexspike.

The approval covers Pfizer and BioNTech’s LP.8.1-adapted monovalent COVID-19 vaccine, which is also indicated for patients aged 5 to 64 with at least 1 underlying condition.

Through considerations regarding cost, scalability, safety, and regulations, researchers provided an end-to-end perspective on microneedle-based vaccine strategies.

Pharmacies face time, workload, and sustainability challenges when integrating social care, but support and reimbursement can make these efforts viable.

However, caution with empagliflozin use should be applied for patients previously taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

The event will focus on patient access and education in pharmacy practice, featuring industry leaders providing actionable strategies and real-world solutions for independent pharmacies.

Certified diabetes care and education specialists and clinical pharmacists are essential members of diabetes care teams.

Among participants in the CATCH trial, researchers explored the relationship between HPV vaccination and incidence of infection.

Joey Mattingly, PharmD, MBA, PhD, discussed the reasons why pharmacies may open or close and where exactly PBMs fall in line amid common pharmacy turnover trends.

A range of evidence-based strategies for managing menstrual pain, such as heat therapy and gentle exercise, can help improve menstrual pain.

Researchers explored the real-world dose titration, adherence rates, and effectiveness of glucagon-like peptide-1 medications among patients in a multidisciplinary obesity clinic.

Cross-training pharmacy staff as community health workers enables pharmacies to effectively address health-related social needs and improve community health outcomes.

Investigators find this association primarily affects female patients when compared with male patients.

The FDA removes the prior requirement for a patient who is already diagnosed with a cardiovascular disease.

Palmer addresses the limitations of alternative methods such as acetaminophen, herbal supplements, and cannabis products, urging patients to consult health care professionals.

In association with patients’ race, ethnicity, and social determinants of health, researchers explored the off-label prescribing of GLP-1s approved for type 2 diabetes.

The Signos Glucose Monitoring System uses body signals that help to improve sleep, manage weight, and decrease the risk of chronic disease.

To better understand its potential role in the pharmacy profession, researchers explore artificial intelligence and the ways pharmacists are aware of its growing implementation.

In an exploration of provider reporting and pharmacovigilance, researchers assessed community pharmacists’ knowledge, attitudes, and practices regarding adverse drug reactions.

Chronic pain affects many older adults, highlighting the need for safe acetaminophen use and effective pain management strategies.

Currently, systemic estrogen replacement therapy is contraindicated for women who have a history of ischemic stroke due to the risk of stroke recurrence.

Sustainable CGM counseling combines pharmacist expertise, technician support, multimodal education, and policy advocacy to improve patient outcomes in diabetes care.

New clinical trial results reveal upadacitinib's effectiveness in achieving significant hair regrowth for patients with severe alopecia areata.

Amid increased concerns of vaccine hesitancy among the parents of pediatric patients, researchers sought the most effective communication methods to curb this growing phenomenon.

Simultaneous vaccination with IIV4 and PPSV23 proves safe and effective for patients with chronic diseases, matching results of healthy individuals.

Integrating health-related social needs programs into pharmacy practice strengthens patient care and positions pharmacies as vital public health partners.

Targeted education and hands-on experience are helping pharmacists gain the confidence needed to guide patients in continuous glucose monitoring.